Advanced nasopharyngeal carcinoma: pre-treatment prediction of progression based on multi-parametric MRI radiomics

doi:10.18632/oncotarget.19799

	Advanced nasopharyngeal carcinoma: pre-treatment prediction of progression based on multi-parametric MRI radiomics
	Zhang, Bin1,2 ; Ouyang, Fusheng 3; Gu, Dongsheng 4; Dong, Yuhao 5; Zhang, Lu 5; Mo, Xiaokai 5; Huang, Wenhui 5; Zhang, Shuixing 1,2
发表期刊	ONCOTARGET
	2017-09-22
卷号	8 期号:42 页码:72457-72465
文章类型	Article
摘要	We aimed to investigate the potential of radiomic features of magnetic resonance imaging (MRI) to predict progression in patients with advanced nasopharyngeal carcinoma (NPC). One hundred and thirteen consecutive patients (01/2007-07/2013) (training cohort: n = 80; validation cohort: n = 33) with advanced NPC were enrolled. A total of 970 initial features were extracted from T2-weighted (T2-w) (n = 485) and contrast-enhanced T1-weighted (CET1-w) MRI (n = 485) for each patient. We used least absolute shrinkage and selection operator (Lasso) method to select features that were most significantly associated with the progression. The selected features were used to construct radiomics-based models and the predictive performance of which were assessed with respect to the area under the curve (AUC). As a result, eight features significantly associated with the progression of advanced NPC were identified. In the training cohort, a radiomic model based on combined CET1-w and T2-w images (AUC: 0.886, 95% CI: 0.815-0.956) demonstrated better prognostic performance than models based on CET1-w (AUC: 0.793, 95% CI: 0.698-0.889) or T2-w images alone (AUC: 0.813, 95% CI: 0.721-0.904). These results were confirmed in the validation cohort. Accordingly, MRI-based radiomic biomarkers present high accuracy in the pre-treatment prediction of progression in advanced NPC.
关键词	Imaging Biomarkers Nasopharyngeal Carcinoma Progression Radiomics
WOS标题词	Science & Technology ; Life Sciences & Biomedicine
DOI	10.18632/oncotarget.19799
关键词[WOS]	CELL LUNG-CANCER ; RADIOTHERAPY ; FEATURES ; GLIOBLASTOMA ; RECURRENCE ; IMAGES ; PET
收录类别	SCI
语种	英语
项目资助者	National Scientific Foundation of China(81571664) ; Science and Technology Planning Project of Guangdong Province(2014A020212244 ; 2016A020216020)
WOS研究方向	Oncology ; Cell Biology
WOS类目	Oncology ; Cell Biology
WOS记录号	WOS:000411509400090
引用统计	被引频次：46[WOS] [WOS记录] [WOS相关记录]
文献类型	期刊论文
条目标识符	http://ir.ia.ac.cn/handle/173211/20736
专题	中国科学院分子影像重点实验室
作者单位	1.Jinan Univ, Med Imaging Ctr, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China 2.Jinan Univ, Inst Mol & Funct Imaging, Guangzhou, Guangdong, Peoples R China 3.First Peoples Hosp Shunde, Dept Radiol, Foshan, Peoples R China 4.Chinese Acad Sci, Key Lab Mol Imaging, Beijing, Peoples R China 5.Guangdong Acad Med Sci, Dept Radiol, Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China
推荐引用方式 GB/T 7714	Zhang, Bin,Ouyang, Fusheng,Gu, Dongsheng,et al. Advanced nasopharyngeal carcinoma: pre-treatment prediction of progression based on multi-parametric MRI radiomics[J]. ONCOTARGET,2017,8(42):72457-72465.
APA	Zhang, Bin.,Ouyang, Fusheng.,Gu, Dongsheng.,Dong, Yuhao.,Zhang, Lu.,...&Zhang, Shuixing.(2017).Advanced nasopharyngeal carcinoma: pre-treatment prediction of progression based on multi-parametric MRI radiomics.ONCOTARGET,8(42),72457-72465.
MLA	Zhang, Bin,et al."Advanced nasopharyngeal carcinoma: pre-treatment prediction of progression based on multi-parametric MRI radiomics".ONCOTARGET 8.42(2017):72457-72465.